Stay updated with breaking news from First Response Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
News and Press Release in English on World about Health and Epidemic; published on 7 Jun 2024 by GAVI
Gavi is facing several important milestones in 2024: developing its next five-year strategy, known as “Gavi 6.0,” gearing up for its upcoming replenishment, and welcoming its new CEO. This year presents an opportunity for Gavi’s board and leadership to revisit its approach to ensure continued impact, even amidst resource constraints.
Recent approval by the Vaccine Alliance (Gavi) of a US$1.8 billion African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will support sustainable vaccine manufacturing in Africa is being hailed as a game changer for the continent.
Nearly 18 months after the first administration of a COVID-19 vaccine, incredible progress has been made. Yet despite this progress, inequities between lower and higher income countries are continuing to cost lives and are prolonging the pandemic.
Vaccine: Over $1.8BN Mobilised in Support of Production in Africa